GMP News and Research

RSS

FUJIFILM Diosynth Biotechnologies Enters Strategic Partnership With OXGENE™ To Address Supply Bottlenecks In Gene Therapy Development And Manufacturing

FDB announced a strategic partnership with OXGENE™, an industry leader in the design and development of gene therapy technologies.

From OXGENE 23 Apr 2020

Review investigates stem cell therapy as potential new treatment for preeclampsia

Preeclampsia is the leading cause of death and disability, for both mothers and babies, killing approximately 76,000 mothers and 500,000 babies globally every year. Despite this, the only cure at present is to deliver the placenta and the baby, with the potential for long term complications.

16 Apr 2020

Microneedle patches for potential COVID-19 vaccines or therapeutics

The COVID-19 pandemic is spreading over the world, causing panic and illness on a scale unprecedented in one hundred years. Even while the death toll nears 100,000, with over 1.5 million confirmed cases worldwide, public health experts and medical professionals are battling it using all the weapons available. Unfortunately, these are all too few.

9 Apr 2020

Cobra Biologics and Karolinska Institutet join forces to develop DNA vaccine against COVID-19

Cobra Biologics, an international CDMO for biologics and pharmaceuticals, and the Karolinska Institutet, one of the world’s leading medical universities, today announced they have been awarded €3 million emergency funding by Horizon 2020 for research and development, and phase I clinical trial testing of a DNA vaccine against COVID-19, as part of the OPENCORONA consortium to support global efforts tackling the pandemic.

31 Mar 2020

Scientists track down a potential target for new sleeping sickness drugs

Using ultra-bright X-ray flashes, a team of researchers has tracked down a potential target for new drugs against sleeping sickness: The scientists have decoded the detailed spatial structure of a vital enzyme of the pathogen, the parasite Trypanosoma brucei.

30 Jan 2020

Mycoplasma in Cell Culture: Fighting Back with Rapid Detection Kits

In this interview, discussing the effects of mycoplasma contamination on cell cultures and the development of rapid detection kits that provide answers in just thirty minutes.

From Gold Biotechnology, Inc. 24 Jan 2020

Synthego adopts good manufacturing practices for highest-quality genome engineering for clinical applications

Synthego, the genome engineering company, today announced it has adopted Good Manufacturing Practice standards to provide academic and industry partners with high-quality reagents for use in clinical research and development.

From Synthego Corporation 23 Jan 2020

Synthego adopts GMP standards for producing sgRNA

Synthego has adopted Good Manufacturing Practice standards for producing customized GMP-grade synthetic guide RNA at its facilities, an initiative the company said will benefit its academic and industry customers as they develop advanced cell and gene therapies.

From Synthego Corporation 23 Jan 2020

New approach for the manufacture of Advanced Therapy Medicinal Products

Akron Biotechnology has proposed a new approach for the qualification of ancillary materials for the manufacture of Advanced Therapy Medicinal Products.

22 Jan 2020

Control and Monitor Nanoparticle, Biopharmaceutical and Polymer Product Process

In this interview, Jason Lin, Application Scientist from Wyatt Technology, talks to News-Medical about the new ultraDAWN that is a breakthrough in monitoring nanoparticle biopharmaceutical and polymer product process.

From Waters | Wyatt Technology 10 Dec 2019

Polyplus-transfection expands GMP portfolio to provide additional flexibility for gene and cell therapy developers

Polyplus-transfection(R) SA, the leading biotechnology company that supports gene and cell therapy by supplying innovative transfection solutions, today announces the availability of the first GMP-grade transfection reagent PEIpro(R)-GMP in additional conditioning that will ensure additional flexibility and cost-efficiency.

From Polyplus-transfection 6 Dec 2019

New partnership aims to explore, cultivate innovations in cell and gene therapy

Some patients who have not responded to traditional medicines are now experiencing remarkable recoveries thanks to next-generation immunotherapies. These therapies equip a patient's own immune cells to recognize, target, and destroy cancer cells.

25 Nov 2019

National effort to develop implantable bio-artificial kidney achieves key milestone

The Kidney Project, a national effort to develop an implantable bio-artificial kidney that could eliminate the need for dialysis, will announce a key milestone in a November 7, 2019 presentation at the American Society of Nephrology Kidney Week 2019 conference in Washington, DC.

7 Nov 2019

Cherwell to showcase new ImpactAir ISO-90 microbial air sampler at Pharmig

Cherwell Laboratories, specialist suppliers of environmental monitoring and process validation solutions for the pharmaceutical and related industries, will once again be supporting Pharmig’s Annual Conference.

From Cherwell Laboratories 30 Oct 2019

Pepscan announces increased GMP production capacity to facilitate clients' growth

Today, Pepscan announced that its GMP production capacity has doubled. Pepscan is an all-in-one partner in peptides, building on 25 years of experience in advancing and applying peptide expertise to facilitate clients in the development and production of peptides.

9 Oct 2019

Lonza and Nephron to present results of MODA-ES Platform implementation at 2019 ISPE Meeting & Expo

During the 2019 ISPE Meeting & Expo (27–30 October, Las Vegas, Nevada), Lonza and Nephron Pharmaceuticals Corporation will co-present the results of the first implementation of Lonza’s MODA-ES Platform, a next-generation electronic batch record solution for the pharmaceutical manufacturing industry.

From Lonza 4 Oct 2019

Duke Human Vaccine Institute participates in a large national effort to improve flu shots

As part of a massive national effort to improve and modernize flu shots, the Duke Human Vaccine Institute has received three research contracts from the National Institute of Allergy and Infectious Diseases, with an initial award of approximately $29.6 million in first-year funding.

30 Sep 2019

GMP News and Research

FUJIFILM Diosynth Biotechnologies Enters Strategic Partnership With OXGENE™ To Address Supply Bottlenecks In Gene Therapy Development And Manufacturing

Review investigates stem cell therapy as potential new treatment for preeclampsia

Microneedle patches for potential COVID-19 vaccines or therapeutics

Cobra Biologics and Karolinska Institutet join forces to develop DNA vaccine against COVID-19

Scientists track down a potential target for new sleeping sickness drugs

Mycoplasma in Cell Culture: Fighting Back with Rapid Detection Kits

Synthego adopts good manufacturing practices for highest-quality genome engineering for clinical applications

Synthego adopts GMP standards for producing sgRNA

New approach for the manufacture of Advanced Therapy Medicinal Products

Control and Monitor Nanoparticle, Biopharmaceutical and Polymer Product Process

Polyplus-transfection expands GMP portfolio to provide additional flexibility for gene and cell therapy developers

New partnership aims to explore, cultivate innovations in cell and gene therapy

National effort to develop implantable bio-artificial kidney achieves key milestone

Cherwell to showcase new ImpactAir ISO-90 microbial air sampler at Pharmig

Pepscan announces increased GMP production capacity to facilitate clients' growth

Lonza and Nephron to present results of MODA-ES Platform implementation at 2019 ISPE Meeting & Expo

Duke Human Vaccine Institute participates in a large national effort to improve flu shots

Discovery of combination protein leads to first-in-human clinical trial for leukemia

Tecan to launch Fluent Gx Automation Workstation for use in regulated laboratories

Virginia Tech professor wins NSF grant to study biofilm formation in bacteria

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News